Babraham Research Campus ready for pitching bonanza
Babraham Research Campus is going to be busy on Wednesday(May 15), with the one-day Babraham Investor Conference (BIC) immediately followed by the Accelerate@Babraham pitches, which gives five organisations the chance to work at Babraham for five months.
Both events take place on Wednesday afternoon. The BIC event includes pitches from start-ups looking for investment (session 1 on the programme) and company presentations from more established ventures who are essentially telling the story of how they got to where they are and what they are hoping to achieve next (sessions 2 and 3 on the programme). Speakers from Microbiotica, F-star and PredictImmune are included in the latter section.
“2019 marks the 10th anniversary of our annual Babraham Investor Conference,” Derek Jones, CEO, Babraham Bioscience Technologies, told the Cambridge Independent.
“Having created the event to connect some of the industry’s most experienced investors with life science and med-tech start up and scale up companies seeking investment, it’s extremely satisfying to see the event going from strength to strength.
“The Babraham Investor Conference gives us the opportunity to showcase current opportunities and the campus, but also facilitate the growth and development of the next generation of life science ventures.”
Speaking of the Accelerate@Babraham section of the occasion, head of Babraham Accelerator Dr Karolina Zapadka said: “Our second Accelerate@Babraham competition has elicited a great response.
“I’m delighted to confirm that our highly experienced investment committee has narrowed the applications down to a final list of eight, all of whom will be presenting to our judging panel on Wednesday.
“The eight finalists come from London, Cambridge and the US and cover the fields of therapeutics, diagnostics, medical devices and manufacturing.
“Of those eight, up to five winners will be chosen to take part in the Accelerate@Babraham programme, starting in September.”
The winners will be announced at the end of the event. As well as an extended five-month training programme at the Babraham campus, they will receive on-to-one mentoring from world-class technical and business experts, access to our invaluable life science, healthcare, business and investor networks and £10,000 non-dilutive funding.
